Alfuzosin Versus Placebo in Acute Urinary Retention
Alfuzosin Versus Placebo in Acute Urinary Retention
The primary objective of the study is to investigate if 14 days of treatment with Alfuzosin
 compared to placebo, will increase the number of patients with satisfying spontaneous voiding
 after acute urinary retention treated with Clean Self-Catheterization.

 Furthermore is investigated the safety of the medical treatment and self-catheterization.
Inclusion Criteria:

 -  Men with acute urinary retention and catheterized

 -  Benign hypertrophia of prostate

 -  Patient is diagnosed in Emergency room or at a acute hospitalization

 Exclusion Criteria:

 -  Known prostate cancer

 -  Prior urinary retention within 30 days

 -  Urinary retention occurring in relation to surgery

 -  Blood in urine

 -  Difficult or impossible catheterization

 -  Fever > 38 degree Celsius

 -  Decreased kidney function

 -  Permanent catheter > 14 days

 -  Treatment with alfa 1 blocker within 30 days

 -  Meeting contraindications to treatment with Alfuzosin

 -  Treatment with other drugs for urinary problems

 The above information is not intended to contain all considerations relevant to a patients
 potential participation in a clinical trial.